<?xml version="1.0" encoding="UTF-8"?>
<p id="Par99">the University of Queensland is synthesizing viral surface proteins, under funding from the Coalition for Epidemic Preparedness (CEPI), in the purpose of presenting them more easily to the immune system. The technology of use is Rapid Response, a ‘Molecular clamp’ vaccine platform in which the body is misled to generate antibodies by adding genes of viral proteins. The process is now in the preclinical state, estimated to be on the market 6 months after this news went public [
 <xref ref-type="bibr" rid="CR112">112</xref>, 
 <xref ref-type="bibr" rid="CR113">113</xref>].
</p>
